Phase 2 Readout~quarter
Phase 2 Readout: zumilokibart
- Drug
- zumilokibart
- Indication
- atopic dermatitis
Other upcoming events for APGE
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Get real-time alerts, AI-powered analysis, and full catalyst coverage.